Ep. 217 - Safer CAR Ts & World’s First TIL Therapy
BioCentury This Week
00:00
Advancements in CAR-T Cell Therapy and Safety Switches
Exploration of non-viral CAR-T cell therapies, safety switches, and gene editing technologies to enhance the safety and efficacy of CAR-T cell therapies. Discussion on in vivo delivery methods utilizing lipid nanoparticles and the development of safety switches for mitigating toxicities like cytokine release syndrome. Showcase of Iovance's efforts in scaling up manufacturing capacity for TIL therapy and maximizing viable cell numbers, along with the partnership between Iovance and Wushi Apptech in manufacturing processes.
Transcript
Play full episode
